Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 76.16% is in line with its 5-year average of 74.73%, around the middle of its 5-year range (73.97%–77.39%).
0.46% above its 12-month average of 75.81%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 77.23%.
GROSS MARGIN
76.16%
GROSS MARGIN AVG TTM
75.81%
GROSS MARGIN AVG 3Y
74.78%
GROSS MARGIN AVG 5Y
74.73%
GROSS MARGIN AVG 10Y
74.11%
GROSS MARGIN AVG 15Y
73.13%
GROSS MARGIN AVG 20Y
74.04%
CURRENT VS TTM AVG
+0.46%
CURRENT VS 3Y AVG
+1.85%
CURRENT VS 5Y AVG
+1.92%
CURRENT VS 10Y AVG
+2.77%
CURRENT VS 15Y AVG
+4.15%
CURRENT VS 20Y AVG
+2.86%
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
+61.41%
vs the sector median at left
Market Cap
$2.87B
Gross Margin
58.69%
TTM Avg
59.64%
3Y Avg
63.22%
5Y Avg
64.62%
Market Cap
$2.88B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.68B
Gross Margin
31.95%
TTM Avg
33.09%
3Y Avg
31.97%
5Y Avg
31.83%
Market Cap
$2.68B
Gross Margin
17.61%
TTM Avg
20.09%
3Y Avg
39.91%
5Y Avg
58.59%
Market Cap
$3.18B
Gross Margin
0.00%
TTM Avg
25.88%
3Y Avg
57.90%
5Y Avg
-575.35%
Market Cap
$2.69B
Gross Margin
56.20%
TTM Avg
28.10%
3Y Avg
28.10%
5Y Avg
28.10%
Market Cap
$2.76B
Gross Margin
84.05%
TTM Avg
-197.31%
3Y Avg
-176.53%
5Y Avg
-71811.06%
Market Cap
$3.15B
Gross Margin
91.14%
TTM Avg
90.25%
3Y Avg
87.92%
5Y Avg
58.61%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AtriCure, Inc. (ATRC) | $2.85B | 76.16% | 75.81% | 74.78% | 74.73% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 58.69% | 59.64% | 63.22% | 64.62% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | 0.00% | 0.00% | 0.00% | 0.00% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | 31.95% | 33.09% | 31.97% | 31.83% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 17.61% | 20.09% | 39.91% | 58.59% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.18B | 0.00% | 25.88% | 57.90% | -575.35% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.69B | 56.20% | 28.10% | 28.10% | 28.10% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | 84.05% | -197.31% | -176.53% | -71811.06% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 91.14% | 90.25% | 87.92% | 58.61% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | 0.00% | 0.00% | 50.00% | 66.67% |
Gross Margin
76.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 77.23% |
| 2026-03-31 | 77.39% |
| 2025-12-31 | 74.43% |
| 2025-09-30 | 75.47% |
| 2025-06-30 | 74.54% |
| 2025-03-31 | 74.93% |
| 2024-12-31 | 74.53% |
| 2024-09-30 | 74.88% |
| 2024-06-30 | 74.04% |
| 2024-03-31 | 73.98% |
| 2023-12-31 | 74.22% |
| 2023-09-30 | 75.15% |
| 2023-06-30 | 76.38% |
| 2023-03-31 | 74.45% |
| 2022-12-31 | 73.97% |
| 2022-09-30 | 74.13% |
| 2022-06-30 | 75.14% |
| 2022-03-31 | 74.55% |
| 2021-12-31 | 75.14% |
| 2021-09-30 | 74.12% |
| 2021-06-30 | 75.76% |
| 2021-03-31 | 75.14% |
| 2020-12-31 | 73.52% |
| 2020-09-30 | 73.66% |
| 2020-06-30 | 67.74% |
| 2020-03-31 | 73.06% |
| 2019-12-31 | 73.02% |
| 2019-09-30 | 73.83% |
| 2019-06-30 | 74.51% |
| 2019-03-31 | 73.88% |
| 2018-12-31 | 72.96% |
| 2018-09-30 | 71.98% |
| 2018-06-30 | 73.51% |
| 2018-03-31 | 73.42% |
| 2017-12-31 | 70.95% |
| 2017-09-30 | 73.35% |
| 2017-06-30 | 71.97% |
| 2017-03-31 | 72.71% |
| 2016-12-31 | 70.21% |
| 2016-09-30 | 71.65% |
| 2016-06-30 | 72.64% |
| 2016-03-31 | 72.10% |
| 2015-12-31 | 71.23% |
| 2015-09-30 | 71.53% |
| 2015-06-30 | 70.95% |
| 2015-03-31 | 72.73% |
| 2014-12-31 | 69.42% |
| 2014-09-30 | 70.81% |
| 2014-06-30 | 70.83% |
| 2014-03-31 | 71.06% |
| 2013-12-31 | 71.60% |
| 2013-09-30 | 72.89% |
| 2013-06-30 | 74.03% |
| 2013-03-31 | 72.50% |
| 2012-12-31 | 70.80% |
| 2012-09-30 | 71.56% |
| 2012-06-30 | 69.58% |
| 2012-03-31 | 72.97% |
| 2011-12-31 | 70.04% |
| 2011-09-30 | 72.82% |
| 2011-06-30 | 73.17% |
| 2011-03-31 | 76.06% |
| 2010-12-31 | 75.09% |
| 2010-09-30 | 77.20% |
| 2010-06-30 | 79.12% |
| 2010-03-31 | 76.54% |
| 2009-12-31 | 75.22% |
| 2009-09-30 | 75.32% |
| 2009-06-30 | 77.44% |
| 2009-03-31 | 78.47% |
| 2008-12-31 | 74.29% |
| 2008-09-30 | 77.06% |
| 2008-06-30 | 76.48% |
| 2008-03-31 | 76.12% |
| 2007-12-31 | 80.09% |
| 2007-09-30 | 77.10% |
| 2007-06-30 | 79.38% |
| 2007-03-31 | 79.44% |
| 2006-12-31 | 77.78% |
| 2006-09-30 | 79.85% |
| 2006-06-30 | 81.50% |
| 2006-03-31 | 81.48% |
| 2005-12-31 | 74.96% |
| 2005-09-30 | 71.89% |
| 2005-06-30 | 74.41% |
| 2005-03-31 | 74.40% |
| 2004-12-31 | 72.70% |
| 2004-09-30 | 74.18% |
| 2004-06-30 | 72.97% |
